As cannabis earnings season continues, Benzinga took a look at the quarterly prints from four companies in the sector Monday.
4Front Ventures Reports $6.86M Quarterly Net Loss
The company reported IFRS revenue of $7.52 million and an adjusted EBITDA loss of $4.61 million.
The quarterly net loss was $6.86 million versus a net loss of $2.64 million in the same quarter of 2018.
4Front Ventures finished the quarter with $12.4 million in cash and said it expects to end November with around $13 million in cash and undrawn loans.
The stock was down 1.73% at 40 cents at the time of publication Monday.
WeedMD’s Shares Plummet After Reporting Q3 Results
WeedMD disclosed a quarterly adjusted EBITDA loss of CA$1.97 million versus an adjusted EBITDA loss of CA$662,822 in the prior quarter.
The company posted a net and comprehensive loss of CA$13.4 million versus net and comprehensive income of CA$12.62 million in the previous quarter.
WeedMD shares were down 8.06% at 76 cents at the time of publication.
FSD Pharma’s Stock Falls Upon Reporting Quarterly Net Loss
The company posted a net loss of CA$16.7 million or CA$2.20 per share.
The stock was down 4.3% at $4.60 at the time of publication.
1933 Industries Reports Higher 2019 Loss
Vertically integrated cannabis consumer packaged goods company 1933 Industries Inc. (CSE: TGIF) (OTC: TGIFF) reported fourth-quarter and annual financial results Thursday, with annual revenue of CA$18.06 million, higher than 2018’s CA$12.55 million.
The company’s annual net loss of CA$19.11 million is more than triple the CA$5.73-million figure one year ago.
The adjusted annual EBITDA loss of CA$10.11 million is an increase over its CA$3.08-million loss in 2018.
1933 Industries shares were trading up 0.98% at 17 cents at the time of publication.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.